Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:RE:RE:Resultats financiers ??

So safe to say anywhere in between the 14th and the 23rd. I'm going to guess the 23rd of Nov.  rate and reply

RE:RE:Resultats financiers ??


RE:RE:Resultats financiers ??

Sur le site de TD il est question du 21 novembre mais ils sont trs souvent dans le champs cote date de resultat trimestriels. Le 14 juillet tait la date de leur dernier resultat trimestriel donc more

RE:Resultats financiers ??

Le 23 novembre; date non confirmee (selon 2 sources).  rate and reply

Resultats financiers ??

Quelqu'un sait quand les rsultats financier du 4ieme trimestre, Merci  rate and reply

Price target

We'll a $4 price target from the current $3 is very possible and a great return. However it's just a matter of how long it takes to get to $4 bucks.   rate and reply

RE:Opsens parraine un petit déjeuner de scientifiques à Boston

Tu oublis le pat a la viande et les beans avec un peu de lard ! Et il semble que Mr Laflamme les a tous endormis !  rate and reply

Opsens parraine un petit déjeuner de scientifiques à Boston

Opsens a invit des cardiologues interventionnistes de renom un petit  djeuner. J'aimerais savoir... un djeuner de cardiologues est-ce qu'il y a beaucoup de bacon,de cretons et more

RE:Royal Bank Equity Research Quick Take

Great company , excellent management and a very bright future . Onwards and upwards .  rate and reply

Royal Bank Equity Research Quick Take

This morning RBC published a research saying that the Savvywire has the potential to become a "workhorse" guidewire and they says that Opsens  is a good take over candidate. They more


RBC September 19, 2022 Highlights from the TCT conference - potential for SavvyWire to become a "workhorse" guidewire TSX: OPS | CAD 3.04 | more

RE:Yesterday's La Presse article  rate and reply

About Edwards Lifesciences...

They surely take note of the Opsens potential.. Un super gros dont les ventes sont pres de $ 5.5 Billion  Tavar sales forecast $ 3,5 to $ 3,7 Billion   Nombre d,actions en circulation more

RE:Last Minute

From $ 3,13 in ''one second''  to $ 3,04 on a couple of shares and at 16:00:00 Just to say that the market close at 3,04 is irrelevant and a $ 3,11 closing price is the number more

As I said...

L’entreprise de Qubec OpSens, spcialise en instrumentation mdicale en cardiologie, franchit une nouvelle tape un moment opportun alors que la direction s’apprte rencontrer d’influents cardiologues. more

Yesterday's La Presse article

   rate and reply

Last Minute

It looked like we would close in the green but likely in the last minute of trading, someone bailed and drove the SP down from $3.13 to $3.04. Still an impressive performance during yet another more

RE:RE:Watch out for Board appointments

Agreed. Sp is still attractive with the current FDA approval in hand.  rate and reply

RE:Watch out for Board appointments

Silly puppy, best management around, in every sense............For serious holders, sp stilll looks very inexpensive to me........  rate and reply